tiprankstipranks
Advertisement
Advertisement

ENSC Stock Latest News

ENSC Earnings this Week: How Will it Perform?
Pre-EarningsENSC Earnings this Week: How Will it Perform?
5d ago
ENSC
Ensysce Biosciences Corrects Series B Preferred Stock Designation
PremiumCompany Announcements
Ensysce Biosciences Corrects Series B Preferred Stock Designation
5d ago
8K
ENSC
Ensysce Biosciences announces initiation of ‘Ask Me Anything’ series
PremiumThe Fly
Ensysce Biosciences announces initiation of ‘Ask Me Anything’ series
24d ago
ENSC
Ensysce Biosciences announces publication on MPAR technology
PremiumThe Fly
Ensysce Biosciences announces publication on MPAR technology
25d ago
ENSC
Ensysce Biosciences initiates review of strategic alternatives
PremiumThe Fly
Ensysce Biosciences initiates review of strategic alternatives
1M ago
ENSC
Ensysce Biosciences enrolls 50% of subjects in Phase 3 trial of PF614
PremiumThe FlyEnsysce Biosciences enrolls 50% of subjects in Phase 3 trial of PF614
2M ago
ENSC
Ensysce Biosciences expands global opioid patent portfolio
Premium
The Fly
Ensysce Biosciences expands global opioid patent portfolio
2M ago
ENSC
Ensysce Biosciences Shareholders Approve Key Corporate Actions
Premium
Company Announcements
Ensysce Biosciences Shareholders Approve Key Corporate Actions
3M ago
8K
ENSC
Ensysce Biosciences receives EU patent for ADHD therapy
PremiumThe Fly
Ensysce Biosciences receives EU patent for ADHD therapy
3M ago
ENSC
Ensysce’s PF614 Steps Forward in Phase 3 Post-Surgery Pain Trial: What Investors Should Watch
PremiumCompany Announcements
Ensysce’s PF614 Steps Forward in Phase 3 Post-Surgery Pain Trial: What Investors Should Watch
3M ago
ENSC
Ensysce Biosciences CEO says ‘positioned for continued momentum’
PremiumThe Fly
Ensysce Biosciences CEO says ‘positioned for continued momentum’
3M ago
ENSC
Ensysce Biosciences initiates enrollment in Phase 3 trial of PF614
PremiumThe Fly
Ensysce Biosciences initiates enrollment in Phase 3 trial of PF614
4M ago
ENSC
Ensysce Biosciences files to sell 4.6M shares of common stock for holders
PremiumThe FlyEnsysce Biosciences files to sell 4.6M shares of common stock for holders
4M ago
ENSC
Ensysce Biosciences issued notice of allowance for MPAR tech patent
Premium
The Fly
Ensysce Biosciences issued notice of allowance for MPAR tech patent
4M ago
ENSC
Ensysce Biosciences receives FDA feedback on PF614 manufacturing
Premium
The Fly
Ensysce Biosciences receives FDA feedback on PF614 manufacturing
4M ago
ENSC
Ensysce Biosciences Secures $4M Financing for PF614
PremiumCompany Announcements
Ensysce Biosciences Secures $4M Financing for PF614
4M ago
8K
ENSC
Ensysce Biosciences secures $4M financing
PremiumThe Fly
Ensysce Biosciences secures $4M financing
4M ago
ENSC
Ensysce Biosciences Reports Increased R&D Expenses Amid Net Loss
PremiumCompany Announcements
Ensysce Biosciences Reports Increased R&D Expenses Amid Net Loss
4M ago
ENSC
Ensysce Biosciences’ Innovative Approach to Safer Opioid Use: A Clinical Study Update
PremiumCompany Announcements
Ensysce Biosciences’ Innovative Approach to Safer Opioid Use: A Clinical Study Update
5M ago
ENSC
Ensysce Biosciences releases symposium highlights from PAINWeek 2025
PremiumThe FlyEnsysce Biosciences releases symposium highlights from PAINWeek 2025
6M ago
ENSC
Ensysce Biosciences shares key takeaways from PAINWeek symposium
Premium
The Fly
Ensysce Biosciences shares key takeaways from PAINWeek symposium
7M ago
ENSC
Ensysce Biosciences Advances Opioid Therapy Innovations
Premium
Company Announcements
Ensysce Biosciences Advances Opioid Therapy Innovations
8M ago
ENSC

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >